Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
TecSalud Investigación Clínica
With
Inosan Biopharma
Age
18–55
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Outpatient with a RT-qPCR confirmation of SARS-CoV-2 infection
Body Mass Index (BMI) at screening of 18.0 - 34.9 kg/m\^2
Presence of at least one symptom consistent with COVID-19
Mild illness as defined by no requirement of supplementary oxygen or hospitalization criteria are met
You may not be if
Presence of a risk factor for disease progression documented for COVID-19 such as: uncontrolled diabetes, uncontrolled hypertension, cardiovascular disease, pulmonary disease, COPD, asthma, active cancer, immunosuppression, hypercoagulable states, CKD currently under dialysis
Documented allergy to equine serum proteins
Previous hospitalization due to COVID-19
Supplementary oxygen, invasive ventilation, or mechanical circulatory support requirements
Having received convalescent plasma or intravenous immunoglobulins for the treatment of COVID-19
Previous vaccination or plans to get vaccinated for COVID-19
In the opinion of investigator, other health conditions that suppose an increased risk of progression of disease
Clareo Health | Safety and Efficacy of Anti-SARS-CoV-2 Equine Antibody F(ab')2 Fragments (INOSARS) for Adult Patients With Mild COVID-19
